Glaukos

ISIN US3773221029

WKN A14VCK

Market cap (in EUR)

5,336 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Show more Show less

Healthcare Healthcare Equipment Other Medical Devices United States

Chart

Financials

Key metrics

Market capitalisation, EUR	5,336 m
EPS, EUR	-1.40
P/B ratio	8.2
P/E ratio	-
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	355 m
Net income, EUR	-135 m
Profit margin	-38.17%

What ETF is Glaukos in?

There are 4 ETFs which contain Glaukos. All of these ETFs are listed in the table below. The ETF with the largest weighting of Glaukos is the iShares S&P SmallCap 600 UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares S&P SmallCap 600 UCITS ETF	0.35%	Equity United States Small Cap	1,771
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	Equity World Social/Environmental	488
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.01%	Equity North America Social/Environmental	27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.08%	Equity United States Small Cap	180

Performance

Returns overview

YTD	-34.40%
1 month	+15.63%
3 months	+30.74%
6 months	+9.79%
1 year	-31.23%
3 years	+117.14%
5 years	-
Since inception (MAX)	+98.50%
2024	+94.48%
2023	+82.16%
2022	-
2021	-

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).